Hims & Hers Health, Inc. Q2 2026 Earnings Results vs. Expectations

What the Street expects

QoQ and YoY are what the consensus implies against the prior quarter and the prior year.

Q2 2026 reported results

What to watch

1. Whether the growth line has a floor. +3.8% is the fourth consecutive deceleration. A negative print would be the first outright year-over-year revenue decline in the series; a re-acceleration would be the first evidence the February pressure has passed thro…
2. Whether the loss repeats. One −$0.40 quarter is an event. Two is a trend, and it would recast the cash generation above as timing rather than resilience.
3. Whether free cash flow holds near the 9.8% margin, given it has swung from −$65.2M to +$83.5M inside these five quarters.
4. Any management statement on the three legal threads. An earnings call is one of the few places a company addresses them on the record, which makes Monday the most likely date since February for the questions our coverage left open to actually get answered.

Read more

Estimate against reported

Estimates are the consensus we published on our own preview for that quarter; quarters we did not preview carry the reported figure only. Where a consensus was set on a non-GAAP basis, the reported column shows that same measure.

Every quarter